Exact Mass: 507.1497694
Exact Mass Matches: 507.1497694
Found 280 metabolites which its exact mass value is equals to given mass value 507.1497694
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
POLYOXIN B
Glucoarabin
C17H33NO10S3 (507.12665180000005)
Glucoarabin is a glucosinolic acid and a sulfoxide.
Delphinidin 3-(acetylglucoside)
Isolated from grapes. Delphinidin 3-(acetylglucoside) is found in many foods, some of which are summer grape, common grape, fruits, and highbush blueberry. Delphinidin 3-(acetylglucoside) is found in common grape. Delphinidin 3-(acetylglucoside) is isolated from grapes.
2-Decarboxybetanin
C23H27N2O11+ (507.16147720000004)
2-Decarboxybetanin is found in root vegetables. 2-Decarboxybetanin is a constituent of Beta vulgaris Constituent of Beta vulgaris. 2-Decarboxybetanin is found in root vegetables.
Benzamide, 5-((1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl)dimethoxymethyl)-2-chloro-
C27H26ClN3O5 (507.1560896000001)
Delphinidin 3-(6'-acetylgalactoside)
Delphinidin 3-(6"-acetylgalactoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Delphinidin 3-(6"-acetylgalactoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Delphinidin 3-(6"-acetylgalactoside) can be found in highbush blueberry and lowbush blueberry, which makes delphinidin 3-(6"-acetylgalactoside) a potential biomarker for the consumption of these food products. Delphinidin 3-(6-acetylgalactoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Delphinidin 3-(6"-acetylgalactoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Delphinidin 3-(6"-acetylgalactoside) can be found in highbush blueberry and lowbush blueberry
Delphinidin 3-(6-acetylglucoside)
(2E)-3-[2,3-dihydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-1,4-benzodioxin-6-yl]-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide|thoreliamide B
Ala Cys Glu Trp
C22H29N5O7S (507.17876040000004)
Ala Cys Trp Glu
C22H29N5O7S (507.17876040000004)
Ala Glu Cys Trp
C22H29N5O7S (507.17876040000004)
Ala Glu Trp Cys
C22H29N5O7S (507.17876040000004)
Ala Trp Cys Glu
C22H29N5O7S (507.17876040000004)
Ala Trp Glu Cys
C22H29N5O7S (507.17876040000004)
Cys Ala Glu Trp
C22H29N5O7S (507.17876040000004)
Cys Ala Trp Glu
C22H29N5O7S (507.17876040000004)
Cys Cys Pro Trp
C22H29N5O5S2 (507.16100240000003)
Cys Cys Trp Pro
C22H29N5O5S2 (507.16100240000003)
Cys Asp Asp Arg
Cys Asp Arg Asp
Cys Glu Ala Trp
C22H29N5O7S (507.17876040000004)
Cys Glu Glu Gln
C18H29N5O10S (507.1635054000001)
Cys Glu Gln Glu
C18H29N5O10S (507.1635054000001)
Cys Glu Trp Ala
C22H29N5O7S (507.17876040000004)
Cys Pro Cys Trp
C22H29N5O5S2 (507.16100240000003)
Cys Pro Trp Cys
C22H29N5O5S2 (507.16100240000003)
Cys Gln Glu Glu
C18H29N5O10S (507.1635054000001)
Cys Arg Asp Asp
Cys Trp Ala Glu
C22H29N5O7S (507.17876040000004)
Cys Trp Cys Pro
C22H29N5O5S2 (507.16100240000003)
Cys Trp Glu Ala
C22H29N5O7S (507.17876040000004)
Cys Trp Pro Cys
C22H29N5O5S2 (507.16100240000003)
Asp Cys Asp Arg
Asp Cys Arg Asp
Asp Asp Cys Arg
Asp Asp Met Gln
C18H29N5O10S (507.1635054000001)
Asp Asp Gln Met
C18H29N5O10S (507.1635054000001)
Asp Asp Arg Cys
Asp Glu Met Asn
C18H29N5O10S (507.1635054000001)
Asp Glu Asn Met
C18H29N5O10S (507.1635054000001)
Asp Gly Met Trp
C22H29N5O7S (507.17876040000004)
Asp Gly Trp Met
C22H29N5O7S (507.17876040000004)
Asp Met Asp Gln
C18H29N5O10S (507.1635054000001)
Asp Met Glu Asn
C18H29N5O10S (507.1635054000001)
Asp Met Gly Trp
C22H29N5O7S (507.17876040000004)
Asp Met Asn Glu
C18H29N5O10S (507.1635054000001)
Asp Met Gln Asp
C18H29N5O10S (507.1635054000001)
Asp Met Trp Gly
C22H29N5O7S (507.17876040000004)
Asp Asn Glu Met
C18H29N5O10S (507.1635054000001)
Asp Asn Met Glu
C18H29N5O10S (507.1635054000001)
Asp Asn Pro Tyr
C22H29N5O9 (507.19651840000006)
Asp Asn Tyr Pro
C22H29N5O9 (507.19651840000006)
Asp Pro Asn Tyr
C22H29N5O9 (507.19651840000006)
Asp Pro Tyr Asn
C22H29N5O9 (507.19651840000006)
Asp Gln Asp Met
C18H29N5O10S (507.1635054000001)
Asp Gln Met Asp
C18H29N5O10S (507.1635054000001)
Asp Arg Cys Asp
Asp Arg Asp Cys
Asp Ser Thr Trp
C22H29N5O9 (507.19651840000006)
Asp Ser Trp Thr
C22H29N5O9 (507.19651840000006)
Asp Thr Ser Trp
C22H29N5O9 (507.19651840000006)
Asp Thr Trp Ser
C22H29N5O9 (507.19651840000006)
Asp Trp Gly Met
C22H29N5O7S (507.17876040000004)
Asp Trp Met Gly
C22H29N5O7S (507.17876040000004)
Asp Trp Ser Thr
C22H29N5O9 (507.19651840000006)
Asp Trp Thr Ser
C22H29N5O9 (507.19651840000006)
Asp Tyr Asn Pro
C22H29N5O9 (507.19651840000006)
Asp Tyr Pro Asn
C22H29N5O9 (507.19651840000006)
Glu Ala Cys Trp
C22H29N5O7S (507.17876040000004)
Glu Ala Trp Cys
C22H29N5O7S (507.17876040000004)
Glu Cys Ala Trp
C22H29N5O7S (507.17876040000004)
Glu Cys Glu Gln
C18H29N5O10S (507.1635054000001)
Glu Cys Gln Glu
C18H29N5O10S (507.1635054000001)
Glu Cys Trp Ala
C22H29N5O7S (507.17876040000004)
Glu Asp Met Asn
C18H29N5O10S (507.1635054000001)
Glu Asp Asn Met
C18H29N5O10S (507.1635054000001)
Glu Glu Cys Gln
C18H29N5O10S (507.1635054000001)
Glu Glu Gln Cys
C18H29N5O10S (507.1635054000001)
Glu Met Asp Asn
C18H29N5O10S (507.1635054000001)
Glu Met Asn Asp
C18H29N5O10S (507.1635054000001)
Glu Asn Asp Met
C18H29N5O10S (507.1635054000001)
Glu Asn Met Asp
C18H29N5O10S (507.1635054000001)
Glu Gln Cys Glu
C18H29N5O10S (507.1635054000001)
Glu Gln Glu Cys
C18H29N5O10S (507.1635054000001)
Glu Ser Ser Trp
C22H29N5O9 (507.19651840000006)
Glu Ser Trp Ser
C22H29N5O9 (507.19651840000006)
Glu Trp Ala Cys
C22H29N5O7S (507.17876040000004)
Glu Trp Cys Ala
C22H29N5O7S (507.17876040000004)
Glu Trp Ser Ser
C22H29N5O9 (507.19651840000006)
Gly Asp Met Trp
C22H29N5O7S (507.17876040000004)
Gly Asp Trp Met
C22H29N5O7S (507.17876040000004)
Gly Met Asp Trp
C22H29N5O7S (507.17876040000004)
Gly Met Trp Asp
C22H29N5O7S (507.17876040000004)
Gly Trp Asp Met
C22H29N5O7S (507.17876040000004)
Gly Trp Met Asp
C22H29N5O7S (507.17876040000004)
b-D-Glucopyranosiduronic acid, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxyphenyl, (3S-tr
5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol glucuronide
Met Asp Asp Gln
C18H29N5O10S (507.1635054000001)
Met Asp Glu Asn
C18H29N5O10S (507.1635054000001)
Met Asp Gly Trp
C22H29N5O7S (507.17876040000004)
Met Asp Asn Glu
C18H29N5O10S (507.1635054000001)
Met Asp Gln Asp
C18H29N5O10S (507.1635054000001)
Met Asp Trp Gly
C22H29N5O7S (507.17876040000004)
Met Glu Asp Asn
C18H29N5O10S (507.1635054000001)
Met Glu Asn Asp
C18H29N5O10S (507.1635054000001)
Met Gly Asp Trp
C22H29N5O7S (507.17876040000004)
Met Gly Trp Asp
C22H29N5O7S (507.17876040000004)
Met Asn Asp Glu
C18H29N5O10S (507.1635054000001)
Met Asn Glu Asp
C18H29N5O10S (507.1635054000001)
Met Gln Asp Asp
C18H29N5O10S (507.1635054000001)
Met Trp Asp Gly
C22H29N5O7S (507.17876040000004)
Met Trp Gly Asp
C22H29N5O7S (507.17876040000004)
Asn Asp Glu Met
C18H29N5O10S (507.1635054000001)
Asn Asp Met Glu
C18H29N5O10S (507.1635054000001)
Asn Asp Pro Tyr
C22H29N5O9 (507.19651840000006)
Asn Asp Tyr Pro
C22H29N5O9 (507.19651840000006)
Asn Glu Asp Met
C18H29N5O10S (507.1635054000001)
Asn Glu Met Asp
C18H29N5O10S (507.1635054000001)
Asn Met Asp Glu
C18H29N5O10S (507.1635054000001)
Asn Met Glu Asp
C18H29N5O10S (507.1635054000001)
Asn Pro Asp Tyr
C22H29N5O9 (507.19651840000006)
Asn Pro Tyr Asp
C22H29N5O9 (507.19651840000006)
Asn Tyr Asp Pro
C22H29N5O9 (507.19651840000006)
Asn Tyr Pro Asp
C22H29N5O9 (507.19651840000006)
Pro Cys Cys Trp
C22H29N5O5S2 (507.16100240000003)
Pro Cys Trp Cys
C22H29N5O5S2 (507.16100240000003)
Pro Asp Asn Tyr
C22H29N5O9 (507.19651840000006)
Pro Asp Tyr Asn
C22H29N5O9 (507.19651840000006)
Pro Asn Asp Tyr
C22H29N5O9 (507.19651840000006)
Pro Asn Tyr Asp
C22H29N5O9 (507.19651840000006)
Pro Trp Cys Cys
C22H29N5O5S2 (507.16100240000003)
Pro Tyr Asp Asn
C22H29N5O9 (507.19651840000006)
Pro Tyr Asn Asp
C22H29N5O9 (507.19651840000006)
Gln Cys Glu Glu
C18H29N5O10S (507.1635054000001)
Gln Asp Asp Met
C18H29N5O10S (507.1635054000001)
Gln Asp Met Asp
C18H29N5O10S (507.1635054000001)
Gln Glu Cys Glu
C18H29N5O10S (507.1635054000001)
Gln Glu Glu Cys
C18H29N5O10S (507.1635054000001)
Gln Met Asp Asp
C18H29N5O10S (507.1635054000001)
Arg Cys Asp Asp
Arg Asp Cys Asp
Arg Asp Asp Cys
Ser Asp Thr Trp
C22H29N5O9 (507.19651840000006)
Ser Asp Trp Thr
C22H29N5O9 (507.19651840000006)
Ser Glu Ser Trp
C22H29N5O9 (507.19651840000006)
Ser Glu Trp Ser
C22H29N5O9 (507.19651840000006)
Ser Ser Glu Trp
C22H29N5O9 (507.19651840000006)
Ser Ser Trp Glu
C22H29N5O9 (507.19651840000006)
Ser Thr Asp Trp
C22H29N5O9 (507.19651840000006)
Ser Thr Trp Asp
C22H29N5O9 (507.19651840000006)
Ser Trp Asp Thr
C22H29N5O9 (507.19651840000006)
Ser Trp Glu Ser
C22H29N5O9 (507.19651840000006)
Ser Trp Ser Glu
C22H29N5O9 (507.19651840000006)
Ser Trp Thr Asp
C22H29N5O9 (507.19651840000006)
Thr Asp Ser Trp
C22H29N5O9 (507.19651840000006)
Thr Asp Trp Ser
C22H29N5O9 (507.19651840000006)
Thr Ser Asp Trp
C22H29N5O9 (507.19651840000006)
Thr Ser Trp Asp
C22H29N5O9 (507.19651840000006)
Thr Trp Asp Ser
C22H29N5O9 (507.19651840000006)
Thr Trp Ser Asp
C22H29N5O9 (507.19651840000006)
Trp Ala Cys Glu
C22H29N5O7S (507.17876040000004)
Trp Ala Glu Cys
C22H29N5O7S (507.17876040000004)
Trp Cys Ala Glu
C22H29N5O7S (507.17876040000004)
Trp Cys Cys Pro
C22H29N5O5S2 (507.16100240000003)
Trp Cys Glu Ala
C22H29N5O7S (507.17876040000004)
Trp Cys Pro Cys
C22H29N5O5S2 (507.16100240000003)
Trp Asp Gly Met
C22H29N5O7S (507.17876040000004)
Trp Asp Met Gly
C22H29N5O7S (507.17876040000004)
Trp Asp Ser Thr
C22H29N5O9 (507.19651840000006)
Trp Asp Thr Ser
C22H29N5O9 (507.19651840000006)
Trp Glu Ala Cys
C22H29N5O7S (507.17876040000004)
Trp Glu Cys Ala
C22H29N5O7S (507.17876040000004)
Trp Glu Ser Ser
C22H29N5O9 (507.19651840000006)
Trp Gly Asp Met
C22H29N5O7S (507.17876040000004)
Trp Gly Met Asp
C22H29N5O7S (507.17876040000004)
Trp Met Asp Gly
C22H29N5O7S (507.17876040000004)
Trp Met Gly Asp
C22H29N5O7S (507.17876040000004)
Trp Pro Cys Cys
C22H29N5O5S2 (507.16100240000003)
Trp Ser Asp Thr
C22H29N5O9 (507.19651840000006)
Trp Ser Glu Ser
C22H29N5O9 (507.19651840000006)
Trp Ser Ser Glu
C22H29N5O9 (507.19651840000006)
Trp Ser Thr Asp
C22H29N5O9 (507.19651840000006)
Trp Thr Asp Ser
C22H29N5O9 (507.19651840000006)
Trp Thr Ser Asp
C22H29N5O9 (507.19651840000006)
Tyr Asp Asn Pro
C22H29N5O9 (507.19651840000006)
Tyr Asp Pro Asn
C22H29N5O9 (507.19651840000006)
Tyr Asn Asp Pro
C22H29N5O9 (507.19651840000006)
Tyr Asn Pro Asp
C22H29N5O9 (507.19651840000006)
Tyr Pro Asp Asn
C22H29N5O9 (507.19651840000006)
Tyr Pro Asn Asp
C22H29N5O9 (507.19651840000006)
Trp-Phe4Cl-OH
C26H22ClN3O6 (507.11970620000005)
2-Decarboxybetanin
C23H27N2O11 (507.16147720000004)
Delphinidin 3-(acetylglucoside)
Quinacrine Dihydrochloride Dihydrate
C23H36Cl3N3O3 (507.1822116000001)
Dibutyryl-cGMP sodium
C18H23N5NaO9P (507.11310380000003)
Dibutyryl-cGMP sodium (Bt2cGMP sodium) is a cell-permeable cGMP analogue. Dibutyryl-cGMP sodium preferentially activates cGMP-dependent protein kinase (PKG). Dibutyryl-cGMP sodium inhibits the release of [3H]-arachidonic acid from γ thrombin-stimulated human platelets. Dibutyryl-cGMP sodium induces peripheral antinociception via activation of ATP-sensitive K+ channels[1][2][3].
(S,E)-ETHYL 7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-5-HYDROXY-3-OXOHEPT-6-ENOATE
C24H30FN3O6S (507.18392520000003)
2-[(1E,3Z)-3-CYANO-5-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
C28H30ClN3O4 (507.19247300000006)
CLEBOPRIDE malATE
C24H30ClN3O7 (507.17721800000004)
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clebopride malate is a dopamine antagonist used in the study of functional gastrointestinal disorders.
Benzenesulfonamide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-
C25H25N5O5S (507.15763200000004)
1,3,5-tris[3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzene
SRT 1460
C26H29N5O4S (507.19401540000007)
SRT 1460, a potent Sirtuin-1 (SIRT1) activator with an EC1.5 value of 2.9 μM, shows good selectivity for activation of SIRT1 versus SIRT2 and SIRT3 (EC1.5>300 μM), and is more potent than Resveratrol and the closest sirtuin homologues[1].
Umeclidinium Bromide
C29H34BrNO2 (507.17727640000004)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.
2-[[[2-Amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester
C26H29N5O4S (507.19401540000007)
N-alpha-(2-Naphthylsulfonyl)-N(3-amidino-L-phenylalaninyl)-4-acetyl-piperazine
C26H29N5O4S (507.19401540000007)
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
C25H31O11- (507.18662759999995)
Lonijaposide G
C24H29NO11 (507.17405240000005)
A natural product found in Lonicera japonica.
Lonijaposide F
C24H29NO11 (507.17405240000005)
A natural product found in Lonicera japonica.
Lonijaposide L
C24H29NO11 (507.17405240000005)
A natural product found in Lonicera japonica.
2-[1-[(4-chlorophenyl)-oxomethyl]-5-methoxy-2-methyl-3-indolyl]-N-[(2-hydroxy-5-nitrophenyl)methyl]acetamide
C26H22ClN3O6 (507.11970620000005)
gibberellin A3 O-beta-D-glucoside(1-)
C25H31O11- (507.18662759999995)
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-thiazolylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
C26H26FN5O3S (507.1740298000001)
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
5-chloro-N-[(2R)-2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]propyl]-2-methoxybenzamide
C24H30ClN3O5S (507.1594600000001)
delphinidin 3-O-(6-O-acetyl-beta-D-glucoside)
An anthocyanin cation that is delphinidin substituted at position 3 by a 6-O-acetyl-beta-D-glucosyl residue.
(E/Z)-Sivopixant
C25H22ClN5O5 (507.13093920000006)
(E/Z)-Sivopixant ((E/Z)-S-600918) is a potent P2X3 receptor antagonist with an IC50 of 4 nM. (E/Z)-Sivopixant can be used for respiratory diseases research[1].
Elcubragistat
Elcubragistat (ABX-1431) is a highly potent, selective, and orally available, CNS-penetrant monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 14 nM.
Ibiglustat (succinate)
C24H30FN3O6S (507.18392520000003)
Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].
NTNCB (hydrochloride)
C25H34ClN3O4S (507.1958434000001)
NTNCB (Compound 11) hydrochloride is a potent and selective neuropeptide Y Y5 (NPY Y5) receptor antagonist with a Ki of 8 nM against human Y5[1].
n-[(2r,3r,4r,6r)-6-{[(3s)-3-ethyl-6-hydroxy-1,7,12-trioxo-3,4-dihydro-2h-tetraphen-8-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]ethanimidic acid
(3s)-5-chloro-8-hydroxy-3-methyl-1-oxo-n-[(2r)-1-oxo-3-phenyl-1-(2,3,4-trihydroxybutoxy)propan-2-yl]-3,4-dihydro-2-benzopyran-7-carboximidic acid
C24H26ClNO9 (507.1296016000001)
(12r,15s)-9-ethyl-4,18-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[18.3.1.0⁵,²³.0¹⁵,²¹]tetracosa-1(23),2,4,10,16,18,20-heptaene-6,14,22,24-tetrone
3'-hydroxy-n-demethylrocaglamide
{"Ingredient_id": "HBIN008730","Ingredient_name": "3'-hydroxy-n-demethylrocaglamide","Alias": "NA","Ingredient_formula": "C28H29NO8","Ingredient_Smile": "CNC(=O)C1C(C2(C(C1O)(C3=C(C=C(C=C3O2)OC)OC)O)C4=CC(=C(C=C4)OC)O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9980","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3s,6r)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
5-({2-[(2-hydroxy-1-methyl-5-oxoimidazol-4-ylidene)amino]-5-[(4-methoxyphenyl)methyl]-3-methylimidazol-4-yl}methyl)-2,3-dimethoxycyclohexa-2,5-diene-1,4-dione
2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
(12s,13s,16s)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatetracyclo[19.3.1.0⁵,²⁴.0¹⁶,²²]pentacosa-1(24),2,4,10,17,19,21-heptaene-6,15,23,25-tetrone
(9r,10e,12s,13s,16s)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatetracyclo[19.3.1.0⁵,²⁴.0¹⁶,²²]pentacosa-1(24),2,4,10,17,19,21-heptaene-6,15,23,25-tetrone
(2r)-n-(2-{[2-({2,6-dihydroxy-3h-naphtho[2,1-b][1,4]thiazin-5-yl}sulfanyl)ethyl]-c-hydroxycarbonimidoyl}ethyl)-2,4-dihydroxy-3,3-dimethylbutanimidic acid
5-chloro-8-hydroxy-3-methyl-1-oxo-n-[1-oxo-3-phenyl-1-(2,3,4-trihydroxybutoxy)propan-2-yl]-3,4-dihydro-2-benzopyran-7-carboximidic acid
C24H26ClNO9 (507.1296016000001)
n-{6-[(3-ethyl-6-hydroxy-1,7,12-trioxo-3,4-dihydro-2h-tetraphen-8-yl)oxy]-3-hydroxy-2-methyloxan-4-yl}ethanimidic acid
(s)-{[(2s,3s,4s)-2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid
2,5,21,28-tetrahydroxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(28),4(9),5,7,17(29),18(27),22-heptaene-3,10,26-trione
(10e,12r,15s)-9-ethyl-4,18-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[18.3.1.0⁵,²³.0¹⁵,²¹]tetracosa-1(23),2,4,10,16,18,20-heptaene-6,14,22,24-tetrone
3-[2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
(3s,6s)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
(10s)-5,8-dihydroxy-4-[(1s,2s)-2-hydroxy-1-[(5s,6r)-5-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl]propoxy]-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one
(2r,11s,13r,20s,21r,25r)-2,5,21,28-tetrahydroxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(28),4(9),5,7,17(29),18(27),22-heptaene-3,10,26-trione
{[2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid
9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatetracyclo[19.3.1.0⁵,²⁴.0¹⁶,²²]pentacosa-1(24),2,4,10,17,19,21-heptaene-6,15,23,25-tetrone
(10s)-5,8-dihydroxy-4-[(1r,2s)-2-hydroxy-1-[(5s,6r)-5-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl]propoxy]-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one
n-[(2s,3r,4r,6s)-6-{[(3s)-3-ethyl-6-hydroxy-1,7,12-trioxo-3,4-dihydro-2h-tetraphen-8-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]ethanimidic acid
(10s)-4,8-dihydroxy-5-[(1s,2s)-2-hydroxy-1-[(5s,6r)-5-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl]propoxy]-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one
(9s,10e,12s,13s,16s)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatetracyclo[19.3.1.0⁵,²⁴.0¹⁶,²²]pentacosa-1(24),2,4,10,17,19,21-heptaene-6,15,23,25-tetrone
19-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
(1s,3s,4s,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12-trihydroxy-13-{[(2e)-2-methylbut-2-enoyl]oxy}-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylic acid
C21H25N5O10 (507.16013499999997)
(2s,3r,4r,5s,6r)-2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
3-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
3-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
3-carboxy-5-[(1e)-2-[(2s,3r,4s)-5-carboxylato-3-ethenyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]ethenyl]-1-ethylpyridin-1-ium
C24H29NO11 (507.17405240000005)
(2s,3s,4s,5s,6r)-2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
methyl 4-methyl-3,7-dioxo-10-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-5,10-diazatetracyclo[7.4.0.0¹,¹².0²,⁶]trideca-2(6),8-diene-4-carboxylate
(10s)-4,8-dihydroxy-5-[(1r,2s)-2-hydroxy-1-[(5s,6r)-5-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl]propoxy]-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one
[5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-7-ylidene](methyl)oxidanium
[C24H27O12]+ (507.15024420000003)